Pfizer

Showing 30 of 54

Singapore authorises Pfizer COVID-19 vaccine for children aged 6 months through 4 years

29/09/2022

Moderna booster gives more protection against Covid-19 to those over 60 who took Pfizer as primary vaccine: NCID study

17/03/2022

What we know about Pfizer's Paxlovid, the first COVID-19 oral medicine approved for use in Singapore

04/02/2022

HSA greenlights Pfizer's Paxlovid; first oral tablet approved in S'pore for treating adult Covid-19 patients

03/02/2022

Singapore approves Pfizer’s Paxlovid pill for COVID-19 treatment in adult patients

03/02/2022

Trending Topics

Study of S'pore population finds Pfizer, Moderna vaccines offer better protection against Covid-19 compared to Sinovac

15/12/2021

Commentary: Why new COVID-19 antiviral pills are badly needed

05/12/2021

2 doses of Pfizer-BioNTech vaccine plus Moderna booster jab has ‘slight edge’ in reducing Covid-19 risk: MOH study

15/11/2021

Covid-19 treatment pills ‘very promising’ but more data needed to assess benefits: MOH official

08/11/2021

Deep Dive - COVID-19 booster shots and the challenge of vaccine science moving at breakneck speed

23/09/2021 29 mins

Advertisement

Commentary: Why the US FDA is taking a wait-and-see attitude on booster shots for US public

21/09/2021

Pfizer hikes 2021 outlook after vaccine boosts sales, profit

28/07/2021

Talking Point 2021/2022 - S1E12: Should My Child Be Vaccinated?

02/07/2021 22 mins

Benefits of mRNA Covid-19 vaccines outweigh risk of vaccination, say experts in response to letter from doctors

28/06/2021

HealthHub records to be adjusted to reflect ‘Pfizer-BioNTech/Comirnaty’ Covid-19 vaccine category name

23/06/2021

Advertisement